All Stories

  1. Identifying neuropsychologically impaired physicians
  2. Diet in Brain Health and Neurological Disorders: Risk Factors and Treatments
  3. Influence of sex differences in interpreting learning and memory within a clinical sample of older adults
  4. Neuropsychological predictors of patient-reported cognitive decline after deep brain stimulation in Parkinson’s disease
  5. Neuropsychological Analysis of an Amazing Memory
  6. Behavioral Changes in Huntington Disease
  7. Harmonizing Measures of Cognitive Performance Across International Surveys of Aging Using Item Response Theory
  8. Betting on DBS: Effects of subthalamic nucleus deep brain stimulation on risk taking and decision making in patients with Parkinson’s disease.
  9. The Unique and Combined Effects of Apathy and Depression on Cognition in Parkinson’s Disease
  10. Health-care use and cost in dementia caregivers: Longitudinal results from the Predictors Caregiver Study
  11. Social cognition in Alzheimer's disease: A separate construct contributing to dependence
  12. The Role of Neuropsychological Evaluation in Epilepsy Surgery Candidates
  13. Determinants of functional disability in Huntington's disease: Role of cognitive and motor dysfunction
  14. Further Validation of the Internet-Based Dementia Risk Assessment
  15. Change in Body Mass Index Before and After Alzheimer’s Disease Onset
  16. Do Older Adults Use the Method of Loci? Results From the ACTIVE Study
  17. The impact of complex chronic diseases on care utilization among assisted living residents
  18. A New Algorithm for Predicting Time to Disease Endpoints in Alzheimer's Disease Patients
  19. Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease
  20. Prefrontal executive function associated coupling relates to Huntington's disease stage
  21. New antiepileptic drug safety information is not transmitted systematically and accepted by U.S. neurologists
  22. Screening by Telephone in the Alzheimer's Disease Anti-inflammatory Prevention Trial
  23. Correlates of Apathy During the First Year After Traumatic Brain Injury
  24. Internet-Based Screening for Dementia Risk
  25. 12-month incidence, prevalence, persistence, and treatment of mental disorders among individuals recently admitted to assisted living facilities in Maryland
  26. Four-year outcome of mild cognitive impairment: The contribution of executive dysfunction.
  27. Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis
  28. Modeling Learning and Memory Using Verbal Learning Tests: Results From ACTIVE
  29. Parallel but not equivalent: Challenges and solutions for repeated assessment of cognition over time
  30. Brain metabolite alterations and cognitive dysfunction in early Huntington's disease
  31. Selective deficit in spatial location memory in extremely low birth weight children at age six: The PETIT Study
  32. Stressful life event appraisal and coping in patients with psychogenic seizures and those with epilepsy
  33. Measurement Equivalence in ADL and IADL Difficulty Across International Surveys of Aging: Findings From the HRS, SHARE, and ELSA
  34. Cognitive functioning in compulsive hoarding
  35. Personality Assessment Inventory among patients with psychogenic seizures and those with epilepsy
  36. Preliminary findings from an Internet-based dementia risk assessment
  37. Extended results of the Alzheimer’s disease anti-inflammatory prevention trial
  38. Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease
  39. Cognitive Predictors of Everyday Functioning in Older Adults: Results From the ACTIVE Cognitive Intervention Trial
  40. Word list memory predicts everyday function and problem-solving in the elderly: Results from the ACTIVE cognitive intervention trial
  41. Utilization of Antihypertensives, Antidepressants, Antipsychotics, and Hormones in Alzheimer Disease
  42. The Fate of the 0.5s: Predictors of 2-Year Outcome in Mild Cognitive Impairment
  43. A randomized clinical trial of a writing workshop intervention to improve autobiographical memory and well-being in older adults
  44. Auditory confrontation naming in alzheimer's disease
  45. Do patients with psychogenic nonepileptic seizures have positive covert attitudes toward sickness?
  46. A recommended scale for cognitive screening in clinical trials of Parkinson's disease
  47. Episodic Memory in Dementia: Characteristics of New Learning that Differentiate Alzheimer's, Huntington's, and Parkinson's Diseases
  48. Everyday functioning in mild cognitive impairment and its relationship with executive cognition
  49. Gray matter in amnestic mild cognitive impairment: voxel-based morphometry
  50. Predictors of New-Onset Depression After Mild Traumatic Brain Injury
  51. The physical environment influences neuropsychiatric symptoms and other outcomes in assisted living residents
  52. Longitudinal Medication Usage in Alzheimer Disease Patients
  53. Spatial location memory discriminates children born at extremely low birth weight and late-preterm at age three.
  54. Aggression After Traumatic Brain Injury: Prevalence and Correlates
  55. Comparison of Patient and Caregiver Reports of Patient Activity Participation and Its Relationship to Mental Health in Patients With Alzheimer's Disease
  56. Scientific and Ethical Issues Related to Deep Brain Stimulation for Disorders of Mood, Behavior, and Thought
  57. Seizures in Alzheimer Disease
  58. Patterns of Word-List Generation in Mild Cognitive Impairment and Alzheimer's Disease
  59. Correlates of Functional Dependence Among Recently Admitted Assisted Living Residents With and Without Dementia
  60. Television Viewing and People With Dementia Living in Long-Term Care
  61. Bridging from clinical endpoints to estimates of treatment value for external decision makers
  62. Selectivity of executive function deficits in mild cognitive impairment.
  63. The Spectrum of Medical Illness and Medication Use Among Residents of Assisted Living Facilities in Central Maryland
  64. Stimulus type affects Wada memory performance
  65. Measuring Cerebral Atrophy and White Matter Hyperintensity Burden to Predict the Rate of Cognitive Decline in Alzheimer Disease
  66. The Effects of Patient Function and Dependence on Costs of Care in Alzheimer's Disease
  67. CHARACTERISTICS AND OUTCOMES FOR ASSISTED LIVING RESIDENTS WITH DEMENTIA: COMPARING DEMENTIA-SPECIFIC CARE UNITS WITH NON–DEMENTIA-SPECIFIC CARE UNITS
  68. Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)
  69. Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies
  70. Distinct Pools of β-Amyloid in Alzheimer Disease–Affected Brain
  71. Exercise, APOE, and working memory: MEG and behavioral evidence for benefit of exercise in epsilon4 carriers
  72. APOE  4 allele predicts faster cognitive decline in mild Alzheimer disease
  73. Anxiety Symptoms Among Assisted Living Residents
  74. Time of Day Affects Episodic Memory in Older Adults*
  75. Home Health and Informal Care Utilization and Costs Over Time in Alzheimer's Disease
  76. The association between activity participation and time to discharge in the assisted living setting
  77. Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention
  78. Insomnia and daytime sleepiness in people with dementia residing in assisted living: findings from the Maryland Assisted Living Study
  79. Patient Dependence and Longitudinal Changes in Costs of Care in Alzheimer’s Disease
  80. Predictors of Providing Informed Consent or Assent for Research Participation in Assisted Living Residents
  81. Disruptive Behavior as a Predictor in Alzheimer Disease
  82. Intramuscular Testosterone Treatment in Elderly Men: Evidence of Memory Decline and Altered Brain Function
  83. Effect of Dementia and Treatment of Dementia on Time to Discharge from Assisted Living Facilities: The Maryland Assisted Living Study
  84. 2005 INS Presidential Address: Neuropsychological Crimes and Misdemeanors
  85. A comparison of small and large assisted living facilities for the diagnosis and care of dementia: the Maryland Assisted Living Study
  86. Verbal episodic memory declines prior to diagnosis in Huntington's disease
  87. Clinical Characteristics and Longitudinal Changes of Informal Cost of Alzheimer's Disease in the Community
  88. Depression in Assisted Living Is Common and Related to Physical Burden
  89. The Progression of Cognition, Psychiatric Symptoms, and Functional Abilities in Dementia With Lewy Bodies and Alzheimer Disease
  90. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease
  91. Predictors of Caregiver Unawareness and Nontreatment of Dementia Among Residents of Assisted Living Facilities: The Maryland Assisted Living Study
  92. A four-year prospective study of cognitive functioning in Huntington's disease
  93. Commentary on “Aggressive course of disease in dementia”
  94. Functional (“Psychogenic”) Amnesia
  95. Incidence and Predictors of Seizures in Patients with Alzheimer's Disease
  96. Clinical features associated with costs in early AD
  97. The association of CAG repeat length with clinical progression in Huntington disease
  98. Relation of Quantitative Indexes of Concurrent α-Synuclein Abnormalities to Clinical Outcome in Autopsy-Proven Alzheimer Disease
  99. Transition to Nursing Home From Assisted Living Is not Associated With Dementia or Dementia-Related Problem Behaviors
  100. Use of an Italian version of the telephone interview for cognitive status in Alzheimer's disease
  101. Depressive Symptoms in Alzheimer's Disease: Natural Course and Temporal Relation to Function and Cognitive Status
  102. Differential impairment of spatial location memory in Huntington's disease
  103. Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease
  104. Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study
  105. Sleep disturbances in the elderly residing in assisted living: findings from the Maryland Assisted Living Study
  106. Motor signs predict poor outcomes in Alzheimer disease
  107. The Maryland Assisted Living Study: Prevalence, Recognition, and Treatment of Dementia and Other Psychiatric Disorders in the Assisted Living Population of Central Maryland
  108. Cognitive Response to Pharmacological Treatment for Depression in Alzheimer Disease: Secondary Outcomes From the Depression in Alzheimer's Disease Study (DIADS)
  109. Research Consent for Cognitively Impaired Adults
  110. Prevalence of Major Depression One Year after Predictive Testing for Huntington's Disease
  111. Cognitive Impairments in Cerebellar Degeneration: A Comparison With Huntington's Disease
  112. The Cognitive Outcome of Hemispherectomy in 71 Children
  113. Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study
  114. Functional brain changes in presymptomatic Huntington's disease
  115. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease
  116. Predictors of neuropathological severity in 100 patients with Huntington's disease
  117. The Rate of Cognitive Decline and Risk of Reaching Clinical Milestones in Alzheimer Disease
  118. Psychopathological Features in Alzheimer's Disease: Course and Relationship with Cognitive Status
  119. Treating Depression in Alzheimer Disease
  120. Identifying Dementia in High-Risk Community Samples: The Memory and Medical Care Study
  121. Ideomotor limb apraxia in Huntington’s disease: implications for corticostriate involvement
  122. Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals
  123. Longitudinal Assessment of Patient Dependence in Alzheimer Disease
  124. Psychopathology in Patients With Degenerative Cerebellar Diseases: A Comparison to Huntington’s Disease
  125. Neuropsychological Functioning and Its Relationship to Antiphospholipid Antibodies in Patients With Systemic Lupus Erythematosus
  126. BRIEF REPORT Testing Prospective Memory: Does the Value of a Borrowed Item Help People Remember To Get It Back?
  127. Incidence, prevalence, and outcomes of depression in residents of a long-term care facility with dementia
  128. What do Alzheimer's disease patients know about animals? It depends on task structure and presentation format
  129. Inhibition of Return in Aging and Alzheimers Disease: Performance as a Function of Task Demands and Stimulus Timing
  130. Longitudinal Study of Quality of Life in People with Advanced Alzheimer's Disease
  131. “Subcortical” cognitive impairment in patients with systemic lupus erythematosus
  132. Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Sertraline in the Treatment of Depression Complicating Alzheimer’s Disease: Initial Results From the Depression in Alzheimer’s Disease Study
  133. Editorial introduction to Greenwood/West dialogue
  134. Vascular Dementia and Alzheimer's Disease: Is There a Difference?: A Comparison of Symptoms by Disease Duration
  135. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease
  136. Motor disorder in Huntington's disease begins as a dysfunction in error feedback control
  137. Quality of life in dementia patients in long-term care
  138. Conceptual and perceptual implicit memory in Huntington's disease.
  139. Conceptual and perceptual implicit memory in Huntington's disease.
  140. Language recovery after left hemispherectomy in children with late-onset seizures
  141. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease
  142. Effects of Three Types of Memory Training in Normal Elderly
  143. American Academy of Clinical Neurospychology Policy on the Use of Non-Doctoral-Level Personnel in Conducting Clinical Neuropsychological Evaluations
  144. Longitudinal analysis of phonemic clustering and switching during word-list generation in Huntington's disease.
  145. When does Huntington's disease begin?
  146. Introduction to Parkin/Baddeley dialogue
  147. Adjustment to residential placement in Alzheimer disease patients: does premorbid personality matter?
  148. A study of the efficacy of a comprehensive memory enhancement program in healthy elderly persons
  149. Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest Reliability
  150. Why Would You Remove Half a Brain? The Outcome of 58 Children After Hemispherectomy---The Johns Hopkins Experience: 1968 to 1996
  151. The absence of an apolipoprotein ?4 allele is associated with a more aggressive form of Alzheimer's disease
  152. Nelson M. Butters (1937–1995).
  153. Neuropsychological Characteristics of Huntington’s Disease
  154. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls
  155. Nelson M. Butters (1937-1995): Obituary.
  156. Speech-Language Outcomes of Hemispherectomy in Children and Young Adults
  157. Automobile driving in Huntington's disease
  158. Alzheimer's Disease in the National Academy of Sciences—National Research Council Registry of Aging Twin Veterans
  159. Changes in visual fixation and saccadic eye movements in Alzheimer's disease
  160. Stability of performance on the Hopkins Verbal Learning Test
  161. Head injury as a risk factor in Alzheimer's disease
  162. Ethical considerations in genetic testing: an empirical study of presymptomatic diagnosis of Huntington's disease
  163. EEG power spectra in huntington's disease: Clinical and neuropsychological correlates
  164. Alzheimer's Disease in the NAS-NRC Registry of Aging Twin Veterans
  165. Cognitive Investigations in Huntington’s Disease
  166. Unimpaired Verbal Memory and Oculomotor Control in Asymptomatic Adults With the Genetic Marker for Huntington's Disease
  167. The Higher Functions of Lower Brain
  168. Hereditary Influences on Cognitive Functioning in Older Men
  169. An attempt at memory retraining in severe amnesia: An experimental single-case study
  170. Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study
  171. Long-term retention of implicit learning in Huntington's disease
  172. Are There Neuropsychologic Manifestations of the Gene for Huntington's Disease in Asymptomatic, At-Risk Individuals?
  173. Rating scales in psychogeriatrics and dementia
  174. Alzheimer's Disease in the National Academy of Sciences Registry of Aging Twin Veterans
  175. Aspects of procedural memory are differentially impaired in huntington's disease
  176. Insurance and the Presymptomatic Diagnosis of Delayed-Onset Disease-Reply
  177. Presymptomatic Diagnosis of Delayed-Onset Disease With Linked DNA Markers
  178. Brain atrophy in Huntington's disease
  179. Neuropsychological and neuroradiological correlates in Huntington's disease.
  180. The detection of simulated amnesia.
  181. The Decision to Be Tested for Huntington's Disease
  182. Visual vigilance and psychopathology
  183. The neuropsychology of Huntington's disease
  184. On the dissimilar effects of alcohol and aging on the perception of cognitive failings
  185. Clinical correlates of dementia and disability in Huntington's disease
  186. Defective stimulus set attention in generalized epilepsy
  187. Cognitive Loss and Recovery in Long-term Alcohol Abusers
  188. Patterns of Remote Memory in Amnesic and Demented Patients
  189. Left-Right Confusion and the Perception of Bilateral Symmetry
  190. Auditory phonemic perception in dyslexia: Categorical identification and discrimination of stop consonants